| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/15/2008 | WO2008058037A1 Compounds and compositions as protein kinase inhibitors |
| 05/15/2008 | WO2008057863A1 Therapeutic combination of a panher/vegfr2 kinase inhibitor and a platinum compound |
| 05/15/2008 | WO2008057681A2 Thiophene compounds |
| 05/15/2008 | WO2008057562A1 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 05/15/2008 | WO2008057512A2 Imidazopyrazines as protein kinase inhibitors |
| 05/15/2008 | WO2008057503A2 Compositions including triciribine and taxanes and methods of use thereof |
| 05/15/2008 | WO2008057291A2 Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof |
| 05/15/2008 | WO2008057252A2 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith |
| 05/15/2008 | WO2008056898A1 Caspase inhibitors based on pyridazinone scaffold |
| 05/15/2008 | WO2008056833A1 ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO |
| 05/15/2008 | WO2008056657A1 Lyophilized preparation comprising phenanthridine derivative |
| 05/15/2008 | WO2008056634A1 Novel hydroxyindole derivative |
| 05/15/2008 | WO2008056596A1 Polymeric derivative of nucleic acid metabolic antagonist |
| 05/15/2008 | WO2008056433A1 Dendritic polyamidoamine phthalocyanine derivative |
| 05/15/2008 | WO2008056189A1 18, 21-didesoxymacbecin derivatives for the treatment of cancer |
| 05/15/2008 | WO2008056187A1 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 05/15/2008 | WO2008056148A1 Chemical compounds |
| 05/15/2008 | WO2008056120A1 Adenine derivatives as inhibitors of hsp90 for the treatment of cancer |
| 05/15/2008 | WO2008055997A1 Use of tri-substituted glycerol compounds for the treatment of radiation injuries |
| 05/15/2008 | WO2008055963A1 Novel method for producing organic phosphorus compounds, phosphorus compounds produced using said method, the metal complexes of said compounds, and use of same |
| 05/15/2008 | WO2008055945A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| 05/15/2008 | WO2008055933A1 1,2,3-triazole derivatives as sigma receptor inhibitors |
| 05/15/2008 | WO2008055932A1 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 05/15/2008 | WO2008055889A1 Compositions and methods of treating oncological, inflammatory and autoimmune diseases mediated by sema4a |
| 05/15/2008 | WO2008055875A1 Compound having inhibitory activity on a rho-gtpase cell protein, a process for obtaining the same, pharmaceutical compositions comprision thereof and a method for the treatment of a rho-gtpase cell protein-mediated condition |
| 05/15/2008 | WO2008055854A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same |
| 05/15/2008 | WO2008055842A1 Substituted 6-phenyl-pyrido [2,3-d] pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same |
| 05/15/2008 | WO2008055702A1 Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof |
| 05/15/2008 | WO2008055629A1 Polymorph iii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide |
| 05/15/2008 | WO2008055530A1 Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseases |
| 05/15/2008 | WO2008055386A1 A water-soluble pharmaceutical composition for injection of 17-allyl amino-17-demethoxy geldanamycin |
| 05/15/2008 | WO2008055361A1 E3 UBIQUITM LIGASE MKRNL AS A MARKER FOR MAMMALIAN STEM CELL PLUπPOTENCY AND METHODS AND USES THEREOF |
| 05/15/2008 | WO2008055317A1 Compositions and methods for the treatment of prostate cancer |
| 05/15/2008 | WO2008034866A3 Dbait and uses thereof |
| 05/15/2008 | WO2008032324A3 Combination therapy for tumoral disease treatment |
| 05/15/2008 | WO2008031820A3 Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors |
| 05/15/2008 | WO2008014603A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/15/2008 | WO2008008310A3 Tyrosine kinase inhibitors |
| 05/15/2008 | WO2007136893A3 Anti-fgf19 antibodies and methods using same |
| 05/15/2008 | WO2007082742A8 Isolated organ perfusion combination therapy of cancer |
| 05/15/2008 | WO2007045959A8 Antioxidant and fe2+chelating properties of herbal extracts |
| 05/15/2008 | US20080114285 Energy-activated targeted cancer therapy |
| 05/15/2008 | US20080114070 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
| 05/15/2008 | US20080114069 Methods of inducing terminal differentiation |
| 05/15/2008 | US20080114060 Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Skin Cancer |
| 05/15/2008 | US20080114055 By using [3-(3,4-Dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-2-hydroxypropyl]trimethyl-ammonium chloride to reduce or reverse cachexia or disease-induced body weight loss |
| 05/15/2008 | US20080114042 Compound |
| 05/15/2008 | US20080114031 1,2;5,6-Di-O-isopropylidene-3-deoxy-3-[{(4-chloro-phenyl)amino}-carbonyl]-amino- alpha -D-allofuranoside; |
| 05/15/2008 | US20080114019 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide |
| 05/15/2008 | US20080114017 2-Methyl-1-thioxo-10-(3-trifluoromethoxy-phenyl)-1,2,3a,4,9,10-hexahydro-2,9,10a-triaza-cyclopenta[b]fluoren-3-one; anticarcinogenic agent; solid tumor and leukemia; cell-cycle specific mode of action: DNA replication or interfering directly with basic cellular molecules like DNA |
| 05/15/2008 | US20080114016 5-(3-aminopropyl)-3-methyl-2,5,7,8,9,10-hexahydro-4H-benzo[g]pyrazolo[4,3-c]quinolin-4-one; anticarcinogenic agent; enhance DNA damaging agents by initiating mitosis before DNA repair is complete and thereby causing tumor cell death; in preparation of a anticancer medicaments |
| 05/15/2008 | US20080114015 NF-kB inhibitors and uses thereof |
| 05/15/2008 | US20080114013 Spiroindolinone derivatives |
| 05/15/2008 | US20080114011 Enhancement of Effectiveness of 5-Fluorouracil in Treatment of Tumor Metastases and Cancer |
| 05/15/2008 | US20080114009 Farnesyl Transferase Inhibiting 1,2-Annelated Quinoline Enantiomer |
| 05/15/2008 | US20080114007 8-indan-5-yl-5-oxo-2-(3-piperazin-1-yl-phenylamino)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxylic acid isopropylamide; antiinflammatory, anticarcinogenic agent, cardiovascular disease; glomerulonephritis, immune nephritis, rheumatoid arthritis, asthma, pancreatitis, HIV infection, psoriasis |
| 05/15/2008 | US20080114006 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies |
| 05/15/2008 | US20080114004 Hydrazone derivatives as kinase inhibitors |
| 05/15/2008 | US20080114003 Pyrimidinylisoxazole Derivatives |
| 05/15/2008 | US20080113993 Barbituric acid analogs as therapeutic agents |
| 05/15/2008 | US20080113991 Pyridopyrazines and the use thereof as kinase inhibitors |
| 05/15/2008 | US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 05/15/2008 | US20080113987 2-(2-methylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine; phosphatidylinositol 3-kinase (PI3K) inhibitor; transplantation of organs or tissues, inflammatory bowel diseases, psoriasis or atopic dermatitis, chronic obstructive pulmonary disease, asthma, rheumatoid arthritis, scleroderma |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113954 Supramolecular Metallic Complexes Exhibiting Both DNA Binding and Photocleavage |
| 05/15/2008 | US20080113939 N-geranylgalacturonamide; anticarcinogenic, antitumor agent |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113927 Indolopyrrolocarbazole derivatives and anti-tumor agent |
| 05/15/2008 | US20080113901 Administering agent that induces nitrosylation of hemoglobin andhyperoxic gas |
| 05/15/2008 | US20080113898 Methods for detecting and inhibiting angiogenesis using peptides |
| 05/15/2008 | US20080113351 Nucleotide sequence for prevention and treatment of cell proliferative disorders; antitumor agents |
| 05/15/2008 | US20080113343 Method of Inhibiting Prostate Cancer Cell Proliferation |
| 05/15/2008 | US20080113050 administering plant extracts for the treatment of leukemia; anticarcinogenic agents |
| 05/15/2008 | US20080112975 Inducing adaptive immune response against a tumor or a pathogen via tissue destruction, followed by engraftment of allogenic cell adjuvants to region of tissue destruction; antitumor agents |
| 05/15/2008 | US20080112958 Using epidermal growth factor receptor antagonist as therapeutic tool in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112957 Composition comprising immunoglobulin specific to epidermal growth factor receptor for treatment of cell proliferative disorders |
| 05/15/2008 | US20080112952 Using endothelial growth factor specific immunogllobulin to treat radiation-induced retinopathy |
| 05/15/2008 | US20080112932 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112931 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112919 Tnp-470 polymer conjugates and use thereof |
| 05/15/2008 | US20080112889 Histone deacetylase 8 ( HDAC8); treating T-cell lymphoma by administering a population of autologous T-cells that have been exposed to a selective HDAC8 inhibitor composition ex vivo |
| 05/15/2008 | DE102006053690A1 New anionic cyclopentadienyl-carbohydrate compounds useful in the preparation of metallocene-carbohydrate compound, which is useful to treat cancer |
| 05/15/2008 | CA2669731A1 Anti-human dlk-1 antibody showing anti-tumor activity in vivo |
| 05/15/2008 | CA2669675A1 Combination of er.alpha.+ ligands and histone deacetylase inhibitors for the treatment of cancer |
| 05/15/2008 | CA2669465A1 Imidazopyrazines as protein kinase inhibitors |
| 05/15/2008 | CA2669432A1 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 05/15/2008 | CA2669266A1 Pyridinone compounds |
| 05/15/2008 | CA2669187A1 Bicyclic heterocycles, drugs containing said compounds, the use thereof and methods for preparing same |
| 05/15/2008 | CA2669054A1 18, 21-didesoxymacbecin derivatives for the treatment of cancer |
| 05/15/2008 | CA2669047A1 Novel compounds and methods for their production |
| 05/15/2008 | CA2669034A1 Chemical compounds |
| 05/15/2008 | CA2668996A1 1,2,3-triazole derivatives as sigma receptor inhibitors |
| 05/15/2008 | CA2668994A1 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 05/15/2008 | CA2668923A1 Use of tri-substituted glycerol compounds for the treatment of radiation injuries |
| 05/15/2008 | CA2668748A1 Polymorph iii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide |
| 05/15/2008 | CA2668731A1 Kinase inhibitors and methods for using the same |
| 05/15/2008 | CA2668704A1 Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof |
| 05/15/2008 | CA2668682A1 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives |
| 05/15/2008 | CA2668638A1 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
| 05/15/2008 | CA2668607A1 Nonoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |